BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. (Q42438129)
Jump to navigation
Jump to search
scientific article published on 3 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells. |
scientific article published on 3 July 2008 |
Statements
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells (English)
P Pérez-Galán
M López-Guerra
M Nguyen
N Villamor
E Montserrat